Past Conference Speakers

Past Conference Speakers

John Reed, M.D., Ph.D.

EVP, Pharmaceuticals, Research & Development

Johnson & Johnson Innovative Medicine
John Reed, M.D., Ph.D. EVP, Pharmaceuticals, Research & Development Johnson & Johnson Innovative Medicine

Mike Varney

Former Exectutive VP, Genentech Research & Early Development, Genentech
Mike Varney Former Exectutive VP, Genentech Research & Early Development, Genentech Genentech

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners
Mira Chaurushiya, Ph.D. Managing Director Westlake Village BioPartners

Ben Cravatt, Ph.D.

Professor & Gilula Chair, Chemical Biology

The Scripps Research Institute
Ben Cravatt, Ph.D. Professor & Gilula Chair, Chemical Biology The Scripps Research Institute

Marianne De

CEO, Vir Biotechnology
Marianne De CEO, Vir Biotechnology Vir Biotechnology

Steve Bartz

Vice President Corporate Development, Seattle Genetics
Steve Bartz Vice President Corporate Development, Seattle Genetics Vir Biotechnology

Daniel Estes, Ph.D.

General Partner

Frazier Healthcare Partners
Daniel Estes, Ph.D. General Partner Frazier Healthcare Partners

Stephen Ferruolo, J.D., Ph.D.

Secretary, Professor

USD School of Law
Stephen Ferruolo, J.D., Ph.D. Secretary, Professor USD School of Law

Rusty Gage

President, Salk Institute
Rusty Gage President, Salk Institute USD School of Law

Carol Gallagher

Venture Advisor, New Enterprise Associates, Inc. (NEA)
Carol Gallagher Venture Advisor, New Enterprise Associates, Inc. (NEA)

Kevin Grimes

Professor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine
Kevin Grimes Professor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine

Jeff Hatfield

CEO, Vividion
Jeff Hatfield CEO, Vividion

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck
Grace Han McMahon AVP and Head, Pacific BD&L Merck

Katie Hewitt

Chief Business Officer, Lilly New Ventures at Eli Lilly and Company
Katie Hewitt Chief Business Officer, Lilly New Ventures at Eli Lilly and Company Merck

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures
Richard Heyman, Ph.D. Venture Partner ARCH Ventures

John Hood, Ph.D.

Founder, CEO & Executive Chairman

Endeavor BioMedicines
John Hood, Ph.D. Founder, CEO & Executive Chairman Endeavor BioMedicines

Mike Jung

Distinguished Professor of Chemistry, UCLA
Mike Jung Distinguished Professor of Chemistry, UCLA Endeavor BioMedicines

Chau Quang Khuong

General Partner and Senior Advisor, Catalio Capital Management
Chau Quang Khuong General Partner and Senior Advisor, Catalio Capital Management Endeavor BioMedicines

Scott Lippman

Distinguished Professor of Medicine, Director of the Moores Cancer Center, Chugai Pharmaceutical Chair, and Associate Vice Chancellor at UC San Diego School of Medicine
Scott Lippman Distinguished Professor of Medicine, Director of the Moores Cancer Center, Chugai Pharmaceutical Chair, and Associate Vice Chancellor at UC San Diego School of Medicine Endeavor BioMedicines

Stefan Luzi

Partner, Gilde Healthcare
Stefan Luzi Partner, Gilde Healthcare Endeavor BioMedicines

Carole Nuechterlein

Head

Roche Venture Fund
Carole Nuechterlein Head Roche Venture Fund

Scott Platshon

Partner, EcoR1 Capital, LLC
Scott Platshon Partner, EcoR1 Capital, LLC EcoR1 Capital, LLC

Armin Rump

Director of Global Business Development, Otsuka
Armin Rump Director of Global Business Development, Otsuka EcoR1 Capital, LLC

Camille Samuels

Director

Venrock Boards
Camille Samuels Director Venrock Boards

Jay Stamatis

Vice President, Head of Business Development and Acquisitions

AbbVie
Jay Stamatis Vice President, Head of Business Development and Acquisitions AbbVie

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories
Matt Tremblay, Ph.D. Chief Executive Officer Blackbird Laboratories

Lesley Stolz, Ph.D.

Head, JLABS California
Lesley Stolz, Ph.D. Head, JLABS California Blackbird Laboratories

Alex Szidon, PhD

Chief Business Officer, Resilience
Alex Szidon, PhD Chief Business Officer, Resilience Blackbird Laboratories

Jeffrey Warmke, PhD

Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
Jeffrey Warmke, PhD Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo Blackbird Laboratories

Asish Xavier, Ph.D.

Vice President, Venture Investments

Johnson & Johnson Innovation – JJDC
Asish Xavier, Ph.D. Vice President, Venture Investments Johnson & Johnson Innovation – JJDC